Patents Represented by Attorney Michael D. Rein
  • Patent number: 8097270
    Abstract: The use of nanoparticles of inorganic materials (e.g., synthetic smectite clays) in ophthalmic compositions is described. The nanoparticles are utilized as biologically inert carriers or depots for biocides. The nanoparticles are particularly useful in preventing or reducing the uptake of biocides from ophthalmic compositions by contact lenses, when the compositions are applied to the lenses.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: January 17, 2012
    Assignee: Novartis AG
    Inventors: Howard Allen Ketelson, Nissanke L. Dassanayake, Thomas Christopher Carey, David L. Meadows
  • Patent number: 8093352
    Abstract: Disclosed are polyquaternary ammonium polymers containing polyalkylene oxide groups according to formula (I) wherein [A]x, [B]y and [C]z are poly(alkylene oxides) each independently selected from the group consisting of poly(ethylene oxide), poly(propylene oxide), and poly(butylene oxide); Z is selected from the group consisting of —CH2CH?CHCH2—, —CH2CH2CH2CH2—, —CH2—C?C—CH2—, —CH2CH2—O—CH2CH2—, —CH2—N(CH2CH2)2N—CH2—, —CH2CH(OH)CH(OH)CH2— and —CH2—C6H4—CH2—; R is —(CR1R2)mCR3R4— wherein m is an integer from 0 to 3 and R1, R2, R3 and R4 are independently selected from the group consisting of H, CH3 and CH2CH3; n is an integer from 1 to 30; x is either 0 or an integer from 2 to 20; y is an integer from 2 to 20; z is either 0 or an integer from 2 to 20; R? is a branched or unbranched alkyl group having from 1 to 3 carbon atoms and is optionally substituted by one or two hydroxyl groups; Q1 and Q2 are independently selected from the group consisting of —CH2CH?CHCH2—X, —CH2C?C—CH2—X, —N(R?)2, —N(R?)3, —N(R?)(R?),
    Type: Grant
    Filed: August 5, 2009
    Date of Patent: January 10, 2012
    Assignee: Alcon Research, Ltd.
    Inventors: Ryan DeSousa, Nissanke L. Dassanayake, Howard Allen Ketelson
  • Patent number: 7982056
    Abstract: The present invention is directed to an improved process for producing substantially pure fluorescein, as well as to substantially pure fluorescein compositions prepared by the process. The invention is particularly directed to the provision of pharmaceutical compositions for use in angiography. The substantially pure fluorescein produced by the process of the present invention is low in color, low in sodium chloride content, and substantially free of pyridine.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: July 19, 2011
    Assignee: Alcon Research, Ltd.
    Inventors: Gregory Bydlinski, Robert Gregg Harris, Britt S. Scott
  • Patent number: 7871602
    Abstract: The use of bis-amines to enhance the antimicrobial activity of pharmaceutical compositions is described. The bis-amines are particularly useful for enhancing the antimicrobial activity of aqueous ophthalmic compositions, such as artificial tears or ocular lubricants, and solutions for disinfecting contact lenses.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: January 18, 2011
    Assignee: Alcon, Inc.
    Inventors: Nissanke L. Dassanayake, Thomas Christopher Carey, Ronald L. Schlitzer, David L. Meadows